LR

Liam Ratcliffe

Head of Biotechnology at Access Industries

New York, New York

Investor
VC
Angel

Invests in

Stages:

Series B
Series A
Seed

Sectors:

Therapeutics
Pharmaceuticals
BioTech
New York City

Locations:

New York, New York
  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Biopharmaceuticals
Biotechnology

Education

  • Uo

    MBA

    University of Michigan - Stephen M. Ross School of Business

    (2004 - 2006)

  • Uo

    PhD

    University of Cape Town

    (1991 - 1994)

  • Uo

    MBChB

    University of Cape Town

    (1982 - 1987)

  • Fort Victoria High School

    (1976 - 1980)

Lists including Liam

AM
AR
AG
AH

Based in NYC

2599 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Eliem Therapeutics

Series A

Total Funding: $380M

Shoopy

Seed

Total Funding: $250K

Passage Bio

Series A

Total Funding: $230M

CuraSen Therapeutics

Series A

Total Funding: $55M

Arvinas

Series B

Total Funding: $140M

Aptinyx

Series A

Total Funding: $140M

Neuronetics

Series D

Total Funding: $170M

Deciphera Pharmaceuticals

Series B

Total Funding: $75M

Afferent Pharmaceuticals

Series A

Total Funding: $83M

Cogent Biosciences

Series B

Total Funding: $180M

Karus Therapeutics

Series B

Total Funding: $8M

Convergence Pharmaceuticals

Series A

Total Funding: $35M

Work Experience

AI
Access Industries

2019

  • Head of Biotechnology

    2019

NL
New Leaf Venture Partners

2008 - 2019

  • Managing Director

    2013 - 2019

  • General Partner

    2008 - 2019

PI
Pfizer Inc

1996 - 2008

  • Snr VP, Pfizer Global Research and Development

    1996 - 2008

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.